RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study will be implemented as a retrospective, noninterventional medical record review of patients from routine practice settings who have been diagnosed with a/m non-squamous NSCLC with or without AGA and received at least 1 line of systemic treatment after failing PTC between January 2017 and December 2024.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony diagnoza raka płuca niedrobnokomórkowego stadium zaawansowane (IIIB/IIIC lub IV), bez możliwości wyleczenia przy pomocy operacji lub radioterapii
- •Wiek co najmniej 18 lat w chwili rozpoznania raka
- •Wcześniejsze leczenie chemioterapią opartą na platynie, które nie przyniosło oczekiwanych rezultatów
- •Otrzymanie co najmniej jednej linii leczenia lekami ukierunkowanymi po niepowodzeniu chemioterapii opartej na platynie
- •Dla pacjentów z mutacjami genetycznymi: leczenie zatwierdzonymi lekami celowanymi (np. gegen EGFR, ALK, ROS1, NTRK, BRAF, MET, RET, HER-2)
✗ Disqualifies
- •Obecność innego raka (poza rakiem skóry bazalioma i czerniakiem) w ciągu roku przed włączeniem do badania
- •Udział w badaniu klinicznym testującym nowy lek na raka lub programie wczesnego dostępu do leków od 2018 roku
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 22, 2026
- Sex
- No restrictions
Locations (11)
Research Site
Belo Horizonte, Brazil
Research Site
Belo Horizonte, Brazil
Research Site
Natal, Brazil
Research Site
Porto Alegre, Brazil
Research Site
São José do Rio Preto, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.